Interestingly, Ling et al. [17] found that metformin treatment led to decreased HIF-1α expression in Bel-Fu cells, which was consistent with the previous observation that metformin therapy reduced serum levels of HIF-1α in patients with breast cancer [16]. This evidence concerns the gene HIF1A and breast cancer.